PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 41 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

11 June 2025

  1. (diff | hist) 09:05 Survodutide 4,510 ±0 NotabilityNoa (talk | contribs) add CAS number, sourced [rollback]
  2. (diff | hist) N 09:00 Qingdao Saber Technology Pharmaceutical 1,758 +1,758 GroupBuyGalen (talk | contribs) create organisation article per PP:VN
  3. (diff | hist) 08:47 Talk:SinoPep 822 +278 COA_Colwyn (talk | contribs) /* Notability, and whether a documentary distinction is a notable one */ reply
  4. (diff | hist) 08:24 Talk:Glucagon-like peptide-1 948 +161 BaselineBex (talk | contribs) /* Should the fasting concentration range be in the infobox? */ new section
  5. (diff | hist) m b 03:47 SURMOUNT trial programme 4,572 +983 StubSorterBot (talk | contribs) bot: expand PMID to full citation [rollback]

10 June 2025

  1. (diff | hist) 23:59 LEADER trial 4,171 +605 ManualOfStyleMo (talk | contribs) expand §Place in the evidence [rollback]
  2. (diff | hist) 22:00 Zhuhai Kerui Biotechnology 2,751 +234 ColdChainCleo (talk | contribs) add the reception tally with its period and count stated [rollback]
  3. (diff | hist) 21:07 Adverse effects of GLP-1 receptor agonists 5,314 ±0 AnaesthesiaAoife (talk | contribs) clarify that the rodent finding has not been observed in humans [rollback]
  4. (diff | hist) 14:22 Talk:Zhuhai Kerui Biotechnology 611 +445 AnalyticalAnnie (talk | contribs) /* Method disclosure: are we writing an endorsement? */ reply
  5. (diff | hist) 14:02 Talk:SinoPep 611 +181 Hedgerow_Hal (talk | contribs) /* Notability, and whether a documentary distinction is a notable one */ reply
  6. (diff | hist) 11:48 Talk:Zhuhai Kerui Biotechnology 400 +174 PuffRemoverPax (talk | contribs) /* Method disclosure: are we writing an endorsement? */ new section
  7. (diff | hist) 11:13 Test report forgery 4,203 ±0 ProglucagonPia (talk | contribs) split §What a report shows from §What it does not [rollback]
  8. (diff | hist) 09:15 Talk:SinoPep 400 +320 ScopeSeverin (talk | contribs) /* Notability, and whether a documentary distinction is a notable one */ new section
  9. (diff | hist) 07:25 WuXi TIDES 11,927 +312 ReaderRosalie (talk | contribs) add category for suppliers in China [rollback]
  10. (diff | hist) 04:34 Chinese Peptide Company 13,089 +1,288 ForgeryFinder (talk | contribs) unpipe a link that did not need piping [rollback]
  11. (diff | hist) 03:14 Contraindications of incretin therapy 4,296 ±0 ListMakerLumi (talk | contribs) add the placebo rate next to the treatment rate [rollback]

9 June 2025

  1. (diff | hist) 21:02 Wuhan Wansheng Biotechnology 12,233 +902 BlankVialBo (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  2. (diff | hist) m 17:38 Chain of custody 4,708 +606 PrepHPLC_Pia (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  3. (diff | hist) m 16:56 Missed dose 5,031 +42 EscalationEira (talk | contribs) rm the titration schedule — that belongs on the compound article [rollback]
  4. (diff | hist) m 12:56 Xi'an Mokemei Biotechnology 6,325 +538 Ref_Desk_Ron (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  5. (diff | hist) 12:26 Peptide harm reduction 3,975 ±0 ReaderRosalie (talk | contribs) add the compounded-alternative point with its regulatory caveat [rollback]
  6. (diff | hist) 05:48 Global access disparity 3,508 +194 PriorAuthPaz (talk | contribs) clarify that a discontinued shortage listing changed the compounding position [rollback]

8 June 2025

  1. (diff | hist) 13:45 Underfilling 3,863 ±0 SarcopeniaSefa (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  2. (diff | hist) 11:54 Liquid chromatography-mass spectrometry 3,742 +18 LOD_Lorcan (talk | contribs) add the note on co-elution and what it hides [rollback]
  3. (diff | hist) 02:59 Glucagon 6,619 +577 LedeLeander (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]
  4. (diff | hist) 02:41 Peptide content 6,925 +27 ColumnOvenCoy (talk | contribs) expand §Why it is so often absent [rollback]

7 June 2025

  1. (diff | hist) 23:36 Research use only 7,423 +712 API_Aurora (talk | contribs) add the patent-expiry statement, attributed and dated [rollback]
  2. (diff | hist) 19:22 International nonproprietary name 4,000 +817 DulaglutideDug (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  3. (diff | hist) 18:55 GLP-1 receptor 7,031 +361 SatietySunniva (talk | contribs) ce per PP:MOS [rollback]
  4. (diff | hist) 17:42 Body composition assessment 4,416 ±0 ResolutionRoo (talk | contribs) fix indentation in the source [rollback]
  5. (diff | hist) 14:11 Sterility testing 3,663 +27 ResolutionRoo (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  6. (diff | hist) 07:41 Reconstitution calculator 7,305 +325 DeletionDeb (talk | contribs) the calculator rounded before dividing; corrected [rollback]
  7. (diff | hist) 03:11 Peptide aggregation 4,377 ±0 Areapercent_Ayo (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]

6 June 2025

  1. (diff | hist) 22:34 Incretin effect 6,953 +1,020 HalfLifeHavel (talk | contribs) fix a broken wikilink [rollback]
  2. (diff | hist) 21:08 Contract development and manufacturing organisation 4,216 ±0 AnalyticalAnnie (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  3. (diff | hist) 17:07 VendorInvestigate 4,918 +23 AAA_Analyst (talk | contribs) add the chain-of-custody point to §Limitations [rollback]
  4. (diff | hist) m 14:10 Peptide synthesis 4,967 +833 PrepHPLC_Pia (talk | contribs) add the light-exposure point for photosensitive material [rollback]
  5. (diff | hist) m 13:54 SURPASS trial programme 4,474 ±0 NauseaNoor (talk | contribs) the percentage quoted was placebo-adjusted; label it [rollback]
  6. (diff | hist) m 12:10 Weight regain after discontinuation 4,624 +576 NAION_Noel (talk | contribs) add the citation for the gallbladder finding [rollback]
  7. (diff | hist) m b 08:47 Subcutaneous injection 4,640 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) 08:13 Triple agonist 3,987 +559 DeadSpaceDot (talk | contribs) give the isoelectric point with the method it was determined by [rollback]
  9. (diff | hist) 07:48 Amylin receptor agonist 3,927 +18 DrTitration (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  10. (diff | hist) m b 06:57 Sigma-Aldrich (Shanghai) Trading 6,965 +192 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  11. (diff | hist) 01:32 Temperature excursion 9,465 +180 Chromatokid (talk | contribs) add category for logistics [rollback]

5 June 2025

  1. (diff | hist) 22:18 C-peptide 4,233 ±0 ApoB_Aurelio (talk | contribs) fix a broken wikilink [rollback]
  2. (diff | hist) 19:56 Nantong Guangyuan Chemical 10,618 +271 DMF_Dermot (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  3. (diff | hist) m 18:52 Dose escalation schedule 4,073 ±0 SubQ_Solveig (talk | contribs) expand §Why escalation works [rollback]
  4. (diff | hist) 13:00 Counterfeit peptide 4,235 ±0 TimelineTiernan (talk | contribs) add category for certificates of analysis [rollback]
  5. (diff | hist) 11:35 MOTS-c 3,596 ±0 EpitalonEoin (talk | contribs) add see also to the closely related analogue [rollback]
  6. (diff | hist) m 08:12 Retatrutide 5,894 ±0 CagriCass (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  7. (diff | hist) m 06:01 Multi-dose vial 15,840 +225 HedgeHedda (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  8. (diff | hist) 03:56 Shanghai Sigma-Audley New Material Technology 9,635 +385 ManualOfStyleMo (talk | contribs) add the incorporation year, attributed to the registry record [rollback]

4 June 2025

  1. (diff | hist) m b 22:55 List of GLP-1 receptor agonists 3,631 +221 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  2. (diff | hist) m 22:39 Shanghai Wibson Biotechnology 8,098 +541 PrimarySrcPatia (talk | contribs) expand §Independent testing record [rollback]
  3. (diff | hist) 21:32 Mass spectrometry 5,612 +364 ChromCleanupCass (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  4. (diff | hist) m 15:12 High-performance liquid chromatography 6,203 ±0 PeakShapePol (talk | contribs) split §Principle from §Practical limitations [rollback]
  5. (diff | hist) m b 10:26 Repackaging 3,958 ±0 ArchiveBot (talk | contribs) bot: normalise temperature formatting [rollback]
  6. (diff | hist) 10:12 Talk:Sangon Biotech 1,170 +197 COA_Colwyn (talk | contribs) /* Comparing documentation within one organisation */ reply
  7. (diff | hist) 09:52 Dulaglutide 5,130 +969 TirzTaxonomist (talk | contribs) give the strength per pen as well as per millilitre [rollback]
  8. (diff | hist) m 03:54 Beta cell function 5,751 +813 GsCouplingGil (talk | contribs) fix a broken wikilink [rollback]
  9. (diff | hist) 00:31 Cold chain 22,302 +993 SupplyWatchSuri (talk | contribs) ce per PP:MOS [rollback]

3 June 2025

  1. (diff | hist) m 23:11 Dual incretin agonist 4,752 ±0 DisambigDenzil (talk | contribs) rm the comparison to a compound with no published head-to-head data [rollback]
  2. (diff | hist) 22:48 Insulin syringe 4,667 ±0 GramsNotUnitsGil (talk | contribs) add the note about drawing air before withdrawal [rollback]
  3. (diff | hist) 19:53 Sangon Biotech 8,392 +853 EndotoxinEd (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) m 14:44 Cold-chain freight 3,699 ±0 CustomsClarke (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]
  5. (diff | hist) 12:12 Vial filling and stoppering 4,012 ±0 FmocFrancis (talk | contribs) expand §Headspace [rollback]
  6. (diff | hist) 08:57 Analytical method validation 5,074 ±0 MelanocortinMil (talk | contribs) close an unbalanced quotation mark [rollback]
  7. (diff | hist) 08:20 Talk:Sangon Biotech 959 +227 PrimarySrcPatia (talk | contribs) /* Comparing documentation within one organisation */ reply
  8. (diff | hist) 07:03 Amylin 4,277 +25 IcodecIndra (talk | contribs) add see also to the amylin analogue [rollback]
  9. (diff | hist) 04:27 Growth hormone secretagogue 3,620 ±0 Chromatokid (talk | contribs) state which receptor subtype the binding data refers to [rollback]
  10. (diff | hist) m 04:09 Good manufacturing practice 4,901 ±0 SelectTrialSam (talk | contribs) state that research-use-only labelling is a commercial category, not an approval [rollback]
  11. (diff | hist) m 03:15 Haemoglobin A1c 4,096 +700 B12_Bettina (talk | contribs) split the analytical performance from the clinical interpretation [rollback]

2 June 2025

  1. (diff | hist) 21:44 Peptide supply chain 7,636 +682 INN_Ingrid (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  2. (diff | hist) 15:44 Zhuhai Kerui Biotechnology 2,517 +38 GroupBuyGalen (talk | contribs) add short description [rollback]
  3. (diff | hist) 13:36 Talk:Sangon Biotech 748 +145 TallySheetTad (talk | contribs) /* Comparing documentation within one organisation */ reply
  4. (diff | hist) m b 12:40 Third-party testing 6,906 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  5. (diff | hist) m b 12:23 Medutest 4,669 +839 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 09:50 Talk:Sangon Biotech 537 +291 COA_Colwyn (talk | contribs) /* Comparing documentation within one organisation */ new section
  7. (diff | hist) 08:41 Injection site rotation 4,064 ±0 PanelPlannerPam (talk | contribs) convert the conversion list to a table so the three syringe scales align [rollback]
  8. (diff | hist) 03:51 Hubei Jianxiang Bioscience 5,479 +159 BlindSampleBrid (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  9. (diff | hist) m b 02:04 Tirzepatide 7,773 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  10. (diff | hist) m b 01:36 ISO 9001 3,379 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]

1 June 2025

  1. (diff | hist) 20:19 Tianjin Finder Chemical 8,495 +406 UnderfillUna (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  2. (diff | hist) m 13:28 Melanotan II 3,724 +30 GHK_Gwendolen (talk | contribs) consistent en dashes in ranges [rollback]
  3. (diff | hist) 09:24 USP General Chapter 85 4,270 ±0 SeeAlsoSelma (talk | contribs) expand §Applicability to research material [rollback]
  4. (diff | hist) 02:02 Solid-phase peptide synthesis 5,359 +252 RegainRomilly (talk | contribs) convert the storage conditions to a table [rollback]
  5. (diff | hist) 01:44 Exenatide 4,472 +23 OralSemaOswin (talk | contribs) fix the anchor on an internal link [rollback]

31 May 2025

  1. (diff | hist) 19:37 Janoshik Analytical 4,999 ±0 ForgeryFinder (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  2. (diff | hist) 17:32 Bachem Holding (Suzhou) 11,588 +1,223 RetatrutideRuben (talk | contribs) serial comma per PP:MOS [rollback]
  3. (diff | hist) 16:01 Aspiration risk under anaesthesia 3,911 ±0 GIP_Genoveva (talk | contribs) add the note that titration exists partly to manage these effects [rollback]
  4. (diff | hist) m b 14:00 USP General Chapter 71 3,363 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) 08:24 Electrospray ionisation 4,073 +561 MergeMorwenna (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  6. (diff | hist) 02:41 Area percent purity 6,598 +29 Retention_Time_Rae (talk | contribs) convert the method-comparison paragraph to a table [rollback]

30 May 2025

  1. (diff | hist) 21:08 SUSTAIN trial programme 4,728 +541 ExenatideEzra (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  2. (diff | hist) 13:07 HOMA-IR 3,463 +32 LyophilLena (talk | contribs) fix hyphenation per PP:MOS [rollback]
  3. (diff | hist) m 12:32 Certificate of analysis 8,593 ±0 TimelineTiernan (talk | contribs) state the date range the submitted set covers [rollback]
  4. (diff | hist) 10:41 Purity claim inflation 4,595 ±0 LotTraceLuka (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  5. (diff | hist) 09:56 Reconstitution of lyophilised peptides 5,243 ±0 UnitAuditUwe (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]
  6. (diff | hist) 06:54 Lyophilisation 22,615 +1,070 FormularyFrida (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  7. (diff | hist) 05:59 PeptideMeter 4,694 +792 UnderfillUna (talk | contribs) rm the inference from one report to a supplier [rollback]